- Mapfre reported better-than-expected net income for the first quarter, reaching €275.9 million.
- The net income surpassed analysts’ estimates, which were set at €236.9 million.
- The company achieved gross written and accepted premiums totaling €8.58 billion.
- Analysts had estimated gross premiums to be slightly lower, at €8.19 billion.
- Mapfre’s total revenue for the quarter amounted to €9.89 billion.
- The company has been reviewed by analysts, receiving 6 ‘buy’ recommendations, 3 ‘hold’ ratings, and 5 ‘sell’ recommendations.
“`
A look at Mapfre SA Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 3 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Mapfre SA, a company that offers insurance services in Europe and the Americas, has garnered positive ratings across different factors according to Smartkarma Smart Scores. With a strong momentum score of 5, Mapfre demonstrates robust performance trends that indicate potential growth opportunities. Moreover, the company scores well in value and growth, with scores of 4 in both categories, suggesting promising prospects for long-term investors seeking undervalued assets with growth potential.
While Mapfre’s dividend and resilience scores stand at 3, indicating moderate performance in these areas, the overall outlook for the company appears optimistic based on the Smartkarma Smart Scores. Investors looking for a company with solid growth prospects and a favorable valuation may find Mapfre SA an attractive investment opportunity in the insurance sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
